Skip to main content
SpringerLink
Log in

Preclinical Model and Histopathology Translational Medicine and Renal Denervation

  • Chapter
  • First Online:
Renal Denervation

  • 882 Accesses

Abstract

The prevalence of resistant hypertension, which is defined as failure to achieve control of blood pressure (BP) (<140/90) despite treatment with optimal doses of three or more antihypertensive medications (including diuretics), is as high as 12–15 % of all hypertensive patients. Renal sympathetic denervation is a new treatment option for resistant hypertension. Catheter-radiofrequency renal denervation has demonstrated its efficacy and safety in the SYMPLICITY I, SYMPLICITY II and EnligHTN trials. However, there are still many unanswered questions in this field, and preclinical studies using animal models may help researchers and clinicians to find answers to those questions. Generally, larger animals such as pig, dog, or sheep are needed for the preclinical study. The swine model is frequently used for the preclinical study, since the anatomy of renovascular system is similar to that of humans. A semi-quantitative ordinal grading system is useful, when the changes of nerves, renal artery, and peri-arterial soft tissue induced by renal denervation are evaluated.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–23.

    Article  PubMed  Google Scholar 

  2. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–72.

    Article  CAS  PubMed  Google Scholar 

  3. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13.

    Article  PubMed  Google Scholar 

  4. Gu Q, Burt VL, Dillon CF, Yoon S. Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health and Nutrition Examination Survey, 2001 to 2010. Circulation. 2012;126:2105–14.

    Article  CAS  PubMed  Google Scholar 

  5. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507–20.

    Article  CAS  PubMed  Google Scholar 

  6. Grassi G, Mancia G. New therapeutic approaches for resistant hypertension. J Nephrol. 2012;25:276–81.

    Article  CAS  PubMed  Google Scholar 

  7. Sarafidis PA. Epidemiology of resistant hypertension. J Clin Hypertens (Greenwich). 2011;13:523–8.

    Article  Google Scholar 

  8. Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008;51:1403–19.

    Article  CAS  PubMed  Google Scholar 

  9. Worthley SG, Tsioufis CP, Worthley MI, et al. Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial. Eur Heart J. 2013;34:2132–40.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:1275–81.

    Article  PubMed  Google Scholar 

  11. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376:1903–9.

    Article  PubMed  Google Scholar 

  12. Krum H, Schlaich MP, Bohm M, et al. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study. Lancet. 2014;383:622–9.

    Article  PubMed  Google Scholar 

  13. Ahmed H, Neuzil P, Skoda J, et al. Renal sympathetic denervation using an irrigated radiofrequency ablation catheter for the management of drug-resistant hypertension. JACC Cardiovasc Interv. 2012;5:758–65.

    Article  PubMed  Google Scholar 

  14. Wang Q, Guo R, Rong S, et al. Noninvasive renal sympathetic denervation by extracorporeal high-intensity focused ultrasound in a preclinical canine model. J Am Coll Cardiol. 2013;61:2185–92.

    Article  PubMed  Google Scholar 

  15. Fischell TA, Vega F, Raju N, et al. Ethanol-mediated perivascular renal sympathetic denervation: preclinical validation of safety and efficacy in a porcine model. EuroIntervention. 2013;9:140–7.

    Article  PubMed  Google Scholar 

  16. Rocha-singh K. Renal artery denervation: a brave new frontier. Endovasc Today. 2012; p. 45–53.

    Google Scholar 

  17. Medtronic. Renal denervation. Minneapolis: RDN Press Release; 2014.

    Google Scholar 

  18. Kandzari DE, Bhatt DL, Sobotka PA, et al. Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial. Clin Cardiol. 2012;35:528–35.

    Article  PubMed  Google Scholar 

  19. Mulder J, Hokfelt T, Knuepfer MM, Kopp UC. Renal sensory and sympathetic nerves reinnervate the kidney in a similar time-dependent fashion after renal denervation in rats. Am J Physiol Regul Integr Comp Physiol. 2013;304:R675–82.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Nagasu H, Satoh M, Kuwabara A, et al. Renal denervation reduces glomerular injury by suppressing NAD(P)H oxidase activity in Dahl salt-sensitive rats. Nephrol Dial Transplant. 2010;25:2889–98.

    Article  CAS  PubMed  Google Scholar 

  21. Girchev R, Markova P, Vuchidolova V. Influence of renal denervation on renal effects of acute nitric oxide and ETA/ETB receptor inhibition in conscious normotensive rats. J Physiol Pharmacol. 2006;57:17–27.

    CAS  PubMed  Google Scholar 

  22. Rippy MK, Zarins D, Barman NC, Wu A, Duncan KL, Zarins CK. Catheter-based renal sympathetic denervation: chronic preclinical evidence for renal artery safety. Clin Res Cardiol. 2011;100:1095–101.

    Article  PubMed  Google Scholar 

  23. Lerman LO, Schwartz RS, Grande JP, Sheedy PF, Romero JC. Noninvasive evaluation of a novel swine model of renal artery stenosis. J Am Soc Nephrol. 1999;10:1455–65.

    CAS  PubMed  Google Scholar 

  24. Tellez A, Rousselle S, Palmieri T, et al. Renal artery nerve distribution and density in the porcine model: biologic implications for the development of radiofrequency ablation therapies. Transl Res. 2013;162:381–9.

    Article  PubMed  Google Scholar 

  25. Atherton DS, Deep NL, Mendelsohn FO. Micro-anatomy of the renal sympathetic nervous system: a human postmortem histologic study. Clin Anat. 2012;25:628–33.

    Article  PubMed  Google Scholar 

  26. Sakakura K, Ladich E, Edelman ER et al. Methodological standardization for the preclinical evaluation of renal sympathetic denervation. JACC Cardiovasc Interv. 2014. doi:10.1016/j.jcin.2014.04.024.

  27. Whitney KM, Schwartz Sterman AJ, O’Connor J, Foley GL, Garman RH. Light microscopic sciatic nerve changes in control beagle dogs from toxicity studies. Toxicol Pathol. 2011;39:835–40.

    Article  PubMed  Google Scholar 

  28. Biberthaler P, Mussack T, Wiedemann E, et al. Evaluation of S-100b as a specific marker for neuronal damage due to minor head trauma. World J Surg. 2001;25:93–7.

    Article  CAS  PubMed  Google Scholar 

  29. Pace V, Perentes E, Germann PG. Pheochromocytomas and ganglioneuromas in the aging rats: morphological and immunohistochemical characterization. Toxicol Pathol. 2002;30:492–500.

    Article  PubMed  Google Scholar 

  30. Burgi K, Cavalleri MT, Alves AS, Britto LR, Antunes VR, Michelini LC. Tyrosine hydroxylase immunoreactivity as indicator of sympathetic activity: simultaneous evaluation in different tissues of hypertensive rats. Am J Physiol Regul Integr Comp Physiol. 2011;300:R264–71.

    Article  CAS  PubMed  Google Scholar 

  31. Ammar S, Ladich E, Steigerwald K, Deisenhofer I, Joner M. Pathophysiology of renal denervation procedures: from renal nerve anatomy to procedural parameters. EuroIntervention. 2013;9(Suppl R):R89–95.

    Article  PubMed  Google Scholar 

  32. Wittkampf FH, Nakagawa H, Yamanashi WS, Imai S, Jackman WM. Thermal latency in radiofrequency ablation. Circulation. 1996;93:1083–6.

    Article  CAS  PubMed  Google Scholar 

  33. Steigerwald K, Titova A, Malle C, et al. Morphological assessment of renal arteries after radiofrequency catheter-based sympathetic denervation in a porcine model. J Hypertens. 2012;30:2230–9.

    Article  CAS  PubMed  Google Scholar 

  34. Skanes AC, Dubuc M, Klein GJ, et al. Cryothermal ablation of the slow pathway for the elimination of atrioventricular nodal reentrant tachycardia. Circulation. 2000;102:2856–60.

    Article  CAS  PubMed  Google Scholar 

  35. Deisenhofer I, Zrenner B, Yin YH, et al. Cryoablation versus radiofrequency energy for the ablation of atrioventricular nodal reentrant tachycardia (the CYRANO Study): results from a large multicenter prospective randomized trial. Circulation. 2010;122:2239–45.

    Article  PubMed  Google Scholar 

  36. Skanes AC, Klein G, Krahn A, Yee R. Cryoablation: potentials and pitfalls. J Cardiovasc Electrophysiol. 2004;15:S28–34.

    Article  PubMed  Google Scholar 

  37. Prochnau D, Figulla HR, Romeike BF, et al. Percutaneous catheter-based cryoablation of the renal artery is effective for sympathetic denervation in a sheep model. Int J Cardiol. 2011;152:268–70.

    Article  CAS  PubMed  Google Scholar 

  38. Mabin T, Sapoval M, Cabane V, Stemmett J, Iyer M. First experience with endovascular ultrasound renal denervation for the treatment of resistant hypertension. EuroIntervention. 2012;8:57–61.

    Article  PubMed  Google Scholar 

  39. Ng KK, Poon RT, Chan SC, et al. High-intensity focused ultrasound for hepatocellular carcinoma: a single-center experience. Ann Surg. 2011;253:981–7.

    Article  PubMed  Google Scholar 

  40. Kennedy JE. High-intensity focused ultrasound in the treatment of solid tumours. Nat Rev Cancer. 2005;5:321–7.

    Article  CAS  PubMed  Google Scholar 

  41. Illing RO, Kennedy JE, Wu F, et al. The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population. Br J Cancer. 2005;93:890–5.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  42. Marsac L, Chauvet D, Larrat B, et al. MR-guided adaptive focusing of therapeutic ultrasound beams in the human head. Med Phys. 2012;39:1141–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  43. Aptel F, Charrel T, Lafon C, et al. Miniaturized high-intensity focused ultrasound device in patients with glaucoma: a clinical pilot study. Invest Ophthalmol Vis Sci. 2011;52:8747–53.

    Article  PubMed  Google Scholar 

  44. Waksman R, Barbash IM, Chan R, Randolph P, Makuria AT, Virmani R. Beta radiation for renal nerve denervation: initial feasibility and safety. EuroIntervention. 2013;9:738–44.

    Article  PubMed  Google Scholar 

  45. Streitparth F, Walter A, Stolzenburg N, et al. MR-guided periarterial ethanol injection for renal sympathetic denervation: a feasibility study in pigs. Cardiovasc Intervent Radiol. 2013;36:791–6.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. CVPath Institute, Inc., 19 Firstfield Road, Gaithersburg, MD, 20878, USA

    Kenichi Sakakura MD, Elena Ladich MD, Fumiyuki Otsuka MD, Kazuyuki Yahagi MD, Frank D. Kolodgie PhD, Michael Joner MD & Renu Virmani MD

Authors
  1. Kenichi Sakakura MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elena Ladich MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fumiyuki Otsuka MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kazuyuki Yahagi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Frank D. Kolodgie PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Michael Joner MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Renu Virmani MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Renu Virmani MD .

Editor information

Editors and Affiliations

  1. St. Luke's Medical Center, Phoenix, Arizona, USA

    Richard R. Heuser

  2. Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia

    Markus Schlaich

  3. CardioVascular Center Frankfurt Sankt Katharinen, Frankfurt, Germany

    Horst Sievert

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag London

About this chapter

Cite this chapter

Sakakura, K. et al. (2015). Preclinical Model and Histopathology Translational Medicine and Renal Denervation. In: Heuser, R., Schlaich, M., Sievert, H. (eds) Renal Denervation. Springer, London. https://doi.org/10.1007/978-1-4471-5223-1_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-5223-1_3

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-5222-4

  • Online ISBN: 978-1-4471-5223-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation